caprylates has been researched along with dalteparin in 1 studies
| Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) | Studies (dalteparin) | Trials (dalteparin) | Recent Studies (post-2010) (dalteparin) |
|---|---|---|---|---|---|
| 5,061 | 100 | 2,339 | 5,665 | 1,423 | 2,267 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baughman, RA; Gonze, MD; Leone-Bay, A; Money, SR; Salartash, K; Sternbergh, WC | 1 |
1 other study(ies) available for caprylates and dalteparin
| Article | Year |
|---|---|
Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.
Topics: Administration, Oral; Animals; Anticoagulants; Caprylates; Disease Models, Animal; Drug Carriers; Enoxaparin; Injections, Subcutaneous; Jugular Veins; Male; Partial Thromboplastin Time; Rats; Rats, Sprague-Dawley; Venous Thrombosis | 2000 |